1 | gain | 9,147 |
2 | regain | 542 |
3 | watchers | 35 |
4 | losers | 26 |
5 | discordancy | 24 |
6 | loss-induced | 16 |
7 | loser | 9 |
8 | loss-independent | 7 |
9 | regainers | 7 |
10 | iv-txa | 5 |
11 | cldh | 4 |
12 | pre-rygb | 4 |
13 | loss-associated | 3 |
14 | machines/free | 3 |
15 | neo-vascularisation | 3 |
16 | re-gain | 3 |
17 | wrx | 3 |
18 | 1341±288g | 2 |
19 | 200/0.62 | 2 |
20 | gain.meetze | 2 |
21 | gain.we | 2 |
22 | loss/maintenance | 2 |
23 | lossing | 2 |
24 | +adibw+bd | 1 |
25 | 1.98-2,432.65 | 1 |
26 | 109+/-27 | 1 |
27 | 13.6+/-2.4kg | 1 |
28 | 1780g | 1 |
29 | 1805g | 1 |
30 | 1860g | 1 |
31 | 2605.6 | 1 |
32 | 29.5+/-7.1 | 1 |
33 | 3000g | 1 |
34 | 3238g | 1 |
35 | 32:139-142 | 1 |
36 | 4.59kg | 1 |
37 | 43kg | 1 |
38 | 73.5kg | 1 |
39 | 854bp | 1 |
40 | =99± | 1 |
41 | centile.sample | 1 |
42 | development-both | 1 |
43 | dinitrates | 1 |
44 | endo-xylanase | 1 |
45 | gain-based | 1 |
46 | gain-related | 1 |
47 | gain-that | 1 |
48 | gain.on | 1 |
49 | gain.our | 1 |
50 | gain/day | 1 |
51 | heparin-lmwh | 1 |
52 | heparin-prophylaxis | 1 |
53 | heparin/aspirin/ticlopidine | 1 |
54 | heteroligomers | 1 |
55 | implants-offers | 1 |
56 | lifter | 1 |
57 | lifter/physical | 1 |
58 | loss+/-s.e | 1 |
59 | loss+dietary | 1 |
60 | loss-enhancing | 1 |
61 | loss-only | 1 |
62 | loss-sustaining | 1 |
63 | loss.included | 1 |
64 | loss.study | 1 |
65 | loss.when | 1 |
66 | loss/metabolic | 1 |
67 | loss/month | 1 |
68 | loss/partic | 1 |
69 | loss/smoking | 1 |
70 | loss/sodium | 1 |
71 | maintenance/rebound | 1 |
72 | melanoidine | 1 |
73 | molecules-possibly | 1 |
74 | only.across | 1 |
75 | oxaborole | 1 |
76 | pltx/kg | 1 |
77 | polysaccharide-k | 1 |
78 | re-gainer | 1 |
79 | reducción | 1 |
80 | related-changes | 1 |
81 | respectively.cisapride | 1 |
82 | stabilization/regain | 1 |
83 | statictically | 1 |
84 | sulfhydryl-rich | 1 |
85 | unchanged/increased | 1 |
86 | variables/hypertension | 1 |
87 | viteselen | 1 |
88 | β1-catenin | 1 |
89 | ∼610 | 1 |
90 | ≤1,750 | 1 |
91 | ≥2500g | 1 |
92 | ≥8.000/µl | 1 |
1 | +adibw+bd | 1 |
2 | 1.98-2,432.65 | 1 |
3 | 109+/-27 | 1 |
4 | 13.6+/-2.4kg | 1 |
5 | 1341±288g | 2 |
6 | 1780g | 1 |
7 | 1805g | 1 |
8 | 1860g | 1 |
9 | 200/0.62 | 2 |
10 | 2605.6 | 1 |
11 | 29.5+/-7.1 | 1 |
12 | 3000g | 1 |
13 | 3238g | 1 |
14 | 32:139-142 | 1 |
15 | 4.59kg | 1 |
16 | 43kg | 1 |
17 | 73.5kg | 1 |
18 | 854bp | 1 |
19 | =99± | 1 |
20 | centile.sample | 1 |
21 | cldh | 4 |
22 | development-both | 1 |
23 | dinitrates | 1 |
24 | discordancy | 24 |
25 | endo-xylanase | 1 |
26 | gain | 9,147 |
27 | gain-based | 1 |
28 | gain-related | 1 |
29 | gain-that | 1 |
30 | gain.meetze | 2 |
31 | gain.on | 1 |
32 | gain.our | 1 |
33 | gain.we | 2 |
34 | gain/day | 1 |
35 | heparin-lmwh | 1 |
36 | heparin-prophylaxis | 1 |
37 | heparin/aspirin/ticlopidine | 1 |
38 | heteroligomers | 1 |
39 | implants-offers | 1 |
40 | iv-txa | 5 |
41 | lifter | 1 |
42 | lifter/physical | 1 |
43 | loser | 9 |
44 | losers | 26 |
45 | loss+/-s.e | 1 |
46 | loss+dietary | 1 |
47 | loss-associated | 3 |
48 | loss-enhancing | 1 |
49 | loss-independent | 7 |
50 | loss-induced | 16 |
51 | loss-only | 1 |
52 | loss-sustaining | 1 |
53 | loss.included | 1 |
54 | loss.study | 1 |
55 | loss.when | 1 |
56 | loss/maintenance | 2 |
57 | loss/metabolic | 1 |
58 | loss/month | 1 |
59 | loss/partic | 1 |
60 | loss/smoking | 1 |
61 | loss/sodium | 1 |
62 | lossing | 2 |
63 | machines/free | 3 |
64 | maintenance/rebound | 1 |
65 | melanoidine | 1 |
66 | molecules-possibly | 1 |
67 | neo-vascularisation | 3 |
68 | only.across | 1 |
69 | oxaborole | 1 |
70 | pltx/kg | 1 |
71 | polysaccharide-k | 1 |
72 | pre-rygb | 4 |
73 | re-gain | 3 |
74 | re-gainer | 1 |
75 | reducción | 1 |
76 | regain | 542 |
77 | regainers | 7 |
78 | related-changes | 1 |
79 | respectively.cisapride | 1 |
80 | stabilization/regain | 1 |
81 | statictically | 1 |
82 | sulfhydryl-rich | 1 |
83 | unchanged/increased | 1 |
84 | variables/hypertension | 1 |
85 | viteselen | 1 |
86 | watchers | 35 |
87 | wrx | 3 |
88 | β1-catenin | 1 |
89 | ∼610 | 1 |
90 | ≤1,750 | 1 |
91 | ≥2500g | 1 |
92 | ≥8.000/µl | 1 |
1 | ∼610 | 1 |
2 | ≤1,750 | 1 |
3 | 29.5+/-7.1 | 1 |
4 | 32:139-142 | 1 |
5 | 200/0.62 | 2 |
6 | 1.98-2,432.65 | 1 |
7 | 2605.6 | 1 |
8 | 109+/-27 | 1 |
9 | iv-txa | 5 |
10 | pre-rygb | 4 |
11 | loss/metabolic | 1 |
12 | loss/partic | 1 |
13 | +adibw+bd | 1 |
14 | loss-induced | 16 |
15 | loss.included | 1 |
16 | gain-based | 1 |
17 | unchanged/increased | 1 |
18 | loss-associated | 3 |
19 | gain-related | 1 |
20 | maintenance/rebound | 1 |
21 | loss+/-s.e | 1 |
22 | loss/maintenance | 2 |
23 | respectively.cisapride | 1 |
24 | machines/free | 3 |
25 | oxaborole | 1 |
26 | centile.sample | 1 |
27 | melanoidine | 1 |
28 | heparin/aspirin/ticlopidine | 1 |
29 | endo-xylanase | 1 |
30 | gain.we | 2 |
31 | gain.meetze | 2 |
32 | 3000g | 1 |
33 | ≥2500g | 1 |
34 | 1860g | 1 |
35 | 1780g | 1 |
36 | 1805g | 1 |
37 | 3238g | 1 |
38 | 1341±288g | 2 |
39 | pltx/kg | 1 |
40 | 43kg | 1 |
41 | 13.6+/-2.4kg | 1 |
42 | 73.5kg | 1 |
43 | 4.59kg | 1 |
44 | loss-enhancing | 1 |
45 | loss/smoking | 1 |
46 | loss-sustaining | 1 |
47 | lossing | 2 |
48 | sulfhydryl-rich | 1 |
49 | cldh | 4 |
50 | loss/month | 1 |
51 | development-both | 1 |
52 | heparin-lmwh | 1 |
53 | polysaccharide-k | 1 |
54 | lifter/physical | 1 |
55 | ≥8.000/µl | 1 |
56 | loss/sodium | 1 |
57 | loss.when | 1 |
58 | viteselen | 1 |
59 | gain | 9,147 |
60 | re-gain | 3 |
61 | regain | 542 |
62 | stabilization/regain | 1 |
63 | β1-catenin | 1 |
64 | gain.on | 1 |
65 | variables/hypertension | 1 |
66 | neo-vascularisation | 3 |
67 | reducción | 1 |
68 | 854bp | 1 |
69 | re-gainer | 1 |
70 | loser | 9 |
71 | lifter | 1 |
72 | gain.our | 1 |
73 | related-changes | 1 |
74 | dinitrates | 1 |
75 | heparin-prophylaxis | 1 |
76 | implants-offers | 1 |
77 | watchers | 35 |
78 | heteroligomers | 1 |
79 | regainers | 7 |
80 | losers | 26 |
81 | only.across | 1 |
82 | gain-that | 1 |
83 | loss-independent | 7 |
84 | wrx | 3 |
85 | gain/day | 1 |
86 | discordancy | 24 |
87 | loss.study | 1 |
88 | molecules-possibly | 1 |
89 | statictically | 1 |
90 | loss-only | 1 |
91 | loss+dietary | 1 |
92 | =99± | 1 |